NASDAQ:IMDX | Free Cash Flow | Insight Molecular Diagnostics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$7.64M$613,000.00-$8.25M
2025-12-31-$5.55M$1.48M-$7.02M
2025-03-31-$5.84M$307,000.00-$6.15M
2024-12-31-$5.35M$214,000.00-$5.57M
2024-03-31-$3.83M$24,000.00-$3.85M
2023-12-31-$4.42M$264,000.00-$4.69M
2023-03-31-$8.3M
2022-12-31-$9.65M$802,000.00-$10.45M
2022-03-31-$13.28M$1.56M-$14.84M
2021-12-31-$7.07M$401,000.00-$7.47M
2021-03-31-$9.84M$842,000.00-$10.68M
2020-12-31-$6.14M$166,000.00-$6.31M
2020-03-31-$6.87M$44,000.00-$6.91M
2019-12-31-$5.31M$900,000.00-$6.21M
2019-03-31-$6.72M$7,000.00-$6.73M
2018-12-31-$2.46M$0.00-$2.46M
2018-03-31-$2.75M$5,000.00-$2.76M
2017-12-31-$3.34M$6,000.00-$3.35M
2017-03-31-$3.29M$16,000.00-$3.31M
2016-12-31-$2.51M$87,000.00-$2.6M
2016-03-31-$2.17M$15,000.00-$2.18M
2015-12-31-$1.7M$489,000.00-$2.18M
2015-03-31-$164,000.00$11,000.00-$175,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$22.18M$3.19M-$25.37M
2024-12-31-$20.69M$516,000.00-$21.21M
2023-12-31-$23.33M$281,000.00-$23.61M
2022-12-31-$45.57M$4.34M-$49.91M
2021-12-31-$35.94M$2.25M-$38.19M
2020-12-31-$25.98M$1.23M-$27.21M
2019-12-31-$19.72M$918,000.00-$20.63M
2018-12-31-$11.65M$31,000.00-$11.68M
2017-12-31-$13.39M$91,000.00-$13.48M
2016-12-31-$7.52M$106,000.00-$7.63M
2015-12-31-$4.23M$500,000.00-$4.73M
2014-12-31-$1.16M$9,000.00-$1.17M